Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

11.76%

Threshold

Crossed upwards

Timeline

Published

05.02.2015

Transaction

30.01.2015

Voting rights breakdown

Voting rights acquired11.76%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 3

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBF2400020

Beneficial owner

Corey Goodman

Declared address

Corey Goodman, Marshall

Expiry of the conversion rights under the convertible loan notes. Warrants and options are directly held by venBio Global Strategic Fund L.P. c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, Georg Town,Grand Cayman KYI-9005, Cayman Islands, which is controlled by venBio Global Strategic GP L.P., c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, George Town, Grand Cayman KYI-9005, Cayman Islands, as general partner. venBio Global Strategic GP L.P, in turn, is controlled by venBio Global Strategic GP Ltd., c/o Walkers Corporate Services Limited, Walker House, 87 Mary Street, George Town, Grand Cayman KYI-9005, Cayman Islands, as general partner. venBio Global Strategic GP Ltd. is jointly controlled by Corey Goodman, Marshall, USA, Paul Brooke, New York, USA, and Robert Adelman, Hillsborough, USA. Paul Brooke also hold certain employee options on shares in the Company directly.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open